Prof. Dr. ESEN SAKA TOPÇUOĞLU

Yayın Ağı

Makaleler 52

1. Distinguishing Alzheimer's disease from Parkinson's disease dementia using Enhanced Cued Recall test subscores

ARSAVA E. M., Demirel E., Akyay A., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E.

TURKISH JOURNAL OF NEUROLOGY , cilt.31, sa.1, ss.62-68, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

2. Autoantibodies to Oligodendrocyte Myelin Glycoprotein Antibody (OMGp) are Detected in Patients with Atypical Demyelination

Altinisik C. N., Gerhards R., Mamipour M., Ozen P. A., Yuksel B., Koseoglu M., et al.

MULTIPLE SCLEROSIS JOURNAL , sa.3, ss.686-687, 2024 (SCI-Expanded, Scopus)

3. Perspectives of Family Caregivers of People With Alzheimer's Disease on Caregiving Experience and Needs A Qualitative Study

Kilic B. S., HİÇDURMAZ D., AYHAN Y., SAKA TOPÇUOĞLU E.

JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES , cilt.62, sa.6, ss.36-45, 2024 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

4. Clinical predictors of Alzheimer's disease-like brain atrophy in individuals with memory complaints

Karakasli A. A., Ozkan E., Karacam Dogan M., Cap D., KARAOSMANOĞLU A., KARAHAN S., et al.

BRAIN AND BEHAVIOR , cilt.14, sa.5, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Role of serostatus in pediatric neuromyelitis optica spectrum disorders: A nationwide multicentric study

Solmaz I., ÖNCEL İ. H., Konuşkan B., Erol I., Orgun L. T., Yılmaz Ü., et al.

Multiple Sclerosis and Related Disorders , cilt.77, 2023 (SCI-Expanded, Scopus)

6. Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease

Kaya Z. B., Karakoç E., Mclean P. J., Saka E., Atilla P.

FASEB BioAdvances , cilt.5, sa.7, ss.263-276, 2023 (Scopus)

7. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis

Erkent I., ELİBOL B., Saka E., SAYGI S., Tezer I.

Neurological Sciences , cilt.44, sa.4, ss.1351-1360, 2023 (SCI-Expanded, Scopus)

8. Rhythm Control and Dementia in Patients With Atrial Fibrillation: A Role for Glymphatic System?

Saka E., TOPÇUOĞLU M. A.

Canadian Journal of Cardiology , cilt.39, sa.2, ss.198, 2023 (SCI-Expanded, Scopus)

9. Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum

ATAY L. Ö., Saka E., AKDEMİR Ü. Ö., YETİM ARSAVA E., BALCI E., ARSAVA E. M., et al.

Current Alzheimer research , cilt.20, sa.7, ss.481-495, 2023 (SCI-Expanded, Scopus)

10. Cerebral vasomotor reactivity across the continuum of subjective cognitive impairment, amnestic mild cognitive impairment and probable Alzheimer's dementia: A transcranial Doppler and PET/MRI study

SAKA TOPÇUOĞLU E., ATAY L. Ö., AKDEMİR Ü. Ö., YETİM ARSAVA E., BALCI E., ARSAVA E. M., et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM , cilt.43, sa.1, ss.129-137, 2023 (SCI-Expanded, Scopus)

11. Perivascular PDGFRB+ cells accompany lesion formation and clinical evolution differentially in two different EAE models

Şekerdağ-Kılıç E., Ulusoy C., Atak D., Özkan E., Gökyüzü A. B., Seyaj S., et al.

Multiple Sclerosis and Related Disorders , cilt.69, 2023 (SCI-Expanded, Scopus)

12. What is New in Nuclear Medicine Imaging for Dementia

Saka Topçuoğlu E., AKDEMİR Ü. Ö., ATAY L. Ö.

Noropsikiyatri Arsivi , cilt.59, 2022 (SCI-Expanded, Scopus, TRDizin)

13. Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis

SOLMAZ İ., Doran T., Yousefi M., KONUŞKAN B., Oncel İ. H., Vural A., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Myelin oligodendrocyte glycoprotein antibodies in genetic leukodystrophies

EROĞLU ERTUĞRUL N. G., Yousefi M., Pekguel F., Doran T., Guenbey C., TOPÇU M., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.369, 2022 (SCI-Expanded, Scopus)

15. Investigating myelin oligodendrocyte glycoprotein antibodies in hereditary citrullinemia

Oncel İ. H., Yousefi M., İNCİ A., ARSLAN GÜLTEN Z., TEKE KISA P., Karaca M., et al.

MEDICAL HYPOTHESES , 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Two cases with mitochondrial membrane protein-associated neurodegeneration: genetic features and long-term clinical follow-up

Mercan S., Iseri S. A. U., Yigiter R., Akcakaya N. H., SAKA TOPÇUOĞLU E., Yapici Z.

NEUROCASE , cilt.28, ss.37-41, 2022 (SCI-Expanded, Scopus)

17. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.

MOVEMENT DISORDERS , cilt.36, ss.1676-1688, 2021 (SCI-Expanded, Scopus)

18. Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices

TOPÇUOĞLU M. A., ARSAVA E. M., SAKA TOPÇUOĞLU E.

TURKISH JOURNAL OF NEUROLOGY , cilt.27, sa.2, ss.102-110, 2021 (ESCI, Scopus, TRDizin)

19. The Role of the Dopamine beta-hydroxylase Functional Polymorphism in Patients with Early-Onset Parkinson's Disease in the Turkish Population

Erer S., ERYILMAZ I. E., Colak D. K., EGELİ Ü., ÇEÇENER G., TUNCA B., et al.

TURKISH JOURNAL OF NEUROLOGY , cilt.27, sa.1, ss.21-26, 2021 (ESCI, Scopus, TRDizin)

20. Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study

TEL B. C., KAZKAYASI İ., TELLİ G., Cinar E., Mutluay S. U., YALÇIN ÇAKMAKLI G., et al.

JOURNAL OF RESEARCH IN PHARMACY , cilt.25, sa.3, ss.352-358, 2021 (ESCI, Scopus, TRDizin)

21. Comparative Analysis of Cognitive Profiles of Huntington's and Parkinson's Diseases

YALÇIN ÇAKMAKLI G., Akpulat G. E. G., Celebi O., SAKA TOPÇUOĞLU E., ELİBOL B.

TURKISH JOURNAL OF NEUROLOGY , cilt.26, sa.3, ss.230-234, 2020 (ESCI, Scopus, TRDizin)

22. The COVID-19 from Neurological Overview

Acar T., Demirel E. A., AFSAR N., AKÇALI A., Demir G. A., ALAGÖZ A. N., et al.

TURKISH JOURNAL OF NEUROLOGY , cilt.26, sa.2, ss.58-108, 2020 (ESCI, Scopus, TRDizin)

23. Predictors of progression in primary progressive multiple sclerosis in a large Turkish cohort

Vural A., Derle E., Sayat-Gurel G., KARABUDAK R., Tuncer A.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.38, 2020 (SCI-Expanded, Scopus)

24. Adaptation of the Modified Mini-Mental State Examination (3MS) and Determination of Its Normative Values in Turkey

KARADAĞ ÇAMAN Ö., KARAHAN S., Unal F., Bilir N., SAKA TOPÇUOĞLU E., BARIŞKIN E., et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS , cilt.47, ss.315-322, 2019 (SCI-Expanded, Scopus)

25. The Sole Initial Imaging Finding in Creutzfeldt-Jacob Disease: Focal FDG-PET Hypometabolism

Kilic A. K., Kaymakamzade B., SAKA TOPÇUOĞLU E., Tan E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.56, sa.3, ss.226-228, 2019 (SCI-Expanded, Scopus, TRDizin)

26. The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients

Fernandez I. M., Macrini C., Krumbholz M., Hensbergen P. J., Ederveen A. L. H., Winklmeier S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.10, 2019 (SCI-Expanded, Scopus)

27. Cognitive Dysfunction in Relation to Topography and Burden of Cerebral Microbleeds

BÜYÜKŞERBETÇİ G., SAKA TOPÇUOĞLU E., KARLI OĞUZ H. K., GÖÇMEN R., ARSAVA E. M., TOPÇUOĞLU M. A.

Noropsikiyatri Arsivi-Archives Of Neuropsychiatry , 2018 (SCI-Expanded, Scopus, TRDizin)

28. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale

AKBOSTANCI M. C., Bayram E., Yilmaz V., Rzayev S., ÖZKAN S., Tokcaer A. B., et al.

MOVEMENT DISORDERS CLINICAL PRACTICE , cilt.5, sa.1, ss.54-59, 2018 (ESCI, Scopus)

29. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN

Olgiati S., DOĞU O., Tufekcioglu Z., Diler Y., SAKA TOPÇUOĞLU E., GÜLTEKİN M., et al.

PARKINSONISM & RELATED DISORDERS , cilt.39, ss.64-70, 2017 (SCI-Expanded, Scopus)

30. Post-stroke totally recovery of tremor in a patient with Parkinson's disease

ÖNDER H., SAKA TOPÇUOĞLU E.

NEUROLOGICAL SCIENCES , cilt.38, sa.6, ss.1127-1128, 2017 (SCI-Expanded, Scopus)

31. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Simonsen A. H., Herukka S., Andreasen N., Baldeiras I., Bjerke M., Blennow K., et al.

ALZHEIMERS & DEMENTIA , cilt.13, sa.3, ss.274-284, 2017 (SCI-Expanded, Scopus)

32. New mutations and genotype-phenotype correlation in late-onset Pompe patients

Bekircan-Kurt C. E., Gunes H. N., Yildiz F. G., SAKA TOPÇUOĞLU E., Tan E., ERDEM ÖZDAMAR S.

ACTA NEUROLOGICA BELGICA , cilt.117, sa.1, ss.269-275, 2017 (SCI-Expanded, Scopus)

33. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

Herukka S., Simonsen A. H., Andreasen N., Baldeiras I., Bjerke M., Blennow K., et al.

ALZHEIMERS & DEMENTIA , cilt.13, sa.3, ss.285-295, 2017 (SCI-Expanded, Scopus)

34. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

van Doorn L. J. C. v. W., Gispert J. D., Kuiperij H. B., Claassen J. A. H. R., Arighi A., Baldeiras I., et al.

JOURNAL OF ALZHEIMERS DISEASE , cilt.56, sa.2, ss.543-555, 2017 (SCI-Expanded, Scopus)

35. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions

ERYILMAZ I. E., ÇEÇENER G., Erer S., EGELİ Ü., TUNCA B., ZARİFOĞLU M., et al.

NEUROLOGICAL RESEARCH , cilt.39, sa.11, ss.965-972, 2017 (SCI-Expanded, Scopus)

36. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations

Erer S., EGELİ Ü., ZARİFOĞLU M., Tezcan G., ÇEÇENER G., TUNCA B., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.148, ss.147-153, 2016 (SCI-Expanded, Scopus)

37. Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome

ÖZIŞIK L., Tanriover M., Saka E.

INTERNAL MEDICINE , cilt.55, sa.10, ss.1393-1396, 2016 (SCI-Expanded, Scopus)

38. Default mode network connectivity is linked to cognitive functioning and CSF A beta(1-42) levels in Alzheimer's disease

Celebi O., UZDOGAN A., Oguz K. K., Has A. C., Dolgun A., Cakmakli G. Y., et al.

ARCHIVES OF GERONTOLOGY AND GERIATRICS , cilt.62, ss.125-132, 2016 (SCI-Expanded, Scopus)

39. Isolated central nervous system Whipple's disease: Two cases

VURAL A., Acar N. P., Soylemezoglu F., Oguz K. K., DERİCİOĞLU N., Saka E.

CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.139, ss.91-94, 2015 (SCI-Expanded, Scopus)

40. Short latency afferent inhibition and cognitive functions in multiple system atrophy

Celebi O., Temucin C., Elibol B., Saka E.

MOVEMENT DISORDERS , cilt.28, 2013 (SCI-Expanded, Scopus)

41. Teaching NeuroImages: A neurosyphilis case presenting with atypical neuroradiologic findings

Agayeva N., Karli-Oguz K., SAKA TOPÇUOĞLU E.

NEUROLOGY , cilt.80, sa.11, 2013 (SCI-Expanded, Scopus)

42. Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

del Campo M., Mollenhauer B., Bertolotto A., Engelborghs S., Hampel H., Simonsen A. H., et al.

BIOMARKERS IN MEDICINE , cilt.6, sa.4, ss.419-430, 2012 (SCI-Expanded, Scopus)

43. Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease

Hacioglu G., Seval-Celik Y., TANRIÖVER G., ÖZSOY Ö., SAKA TOPÇUOĞLU E., Balkan S., et al.

FOLIA HISTOCHEMICA ET CYTOBIOLOGICA , cilt.50, sa.2, ss.228-238, 2012 (SCI-Expanded, Scopus)

44. Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats

Cantuti-Castelvetri I., Hernandez L. F., Keller-McGandy C. E., Kett L. R., Landy A., Hollingsworth Z. R., et al.

PLOS ONE , cilt.5, sa.11, 2010 (SCI-Expanded, Scopus)

45. Transcranial sonography in Perry syndrome

SAKA TOPÇUOĞLU E., TOPÇUOĞLU M. A., Demir A. U., ELİBOL B.

PARKINSONISM & RELATED DISORDERS , cilt.16, sa.1, ss.68-70, 2010 (SCI-Expanded, Scopus)

46. PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE: EXPERIMENTAL AND GENETIC FINDINGS

Saka E.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , cilt.13, ss.21-26, 2010 (SCI-Expanded, SSCI, Scopus, TRDizin)

47. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction

SAKA TOPÇUOĞLU E., Elibol B.

PARKINSONISM & RELATED DISORDERS , cilt.15, sa.9, ss.688-691, 2009 (SCI-Expanded, Scopus)

48. Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy

Crittenden J. R., Cantuti-Castelvetri I., SAKA TOPÇUOĞLU E., Keller-McGandy C. E., Hernandez L. F., Kett L. R., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.106, sa.8, ss.2892-2896, 2009 (SCI-Expanded, Scopus)

49. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD)

Saka E., Dogan E. A., Topcuoglu M. A., Senol U., Balkan S.

ARCHIVES OF GERONTOLOGY AND GERIATRICS , cilt.44, sa.2, ss.141-151, 2007 (SCI-Expanded, Scopus)

50. Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer's disease and mild cognitive impairment in Turkish people.

Saka E., Mihci E., Topcuoglu M. A., Balkan S.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists , cilt.21, sa.7, ss.745-51, 2006 (SCI-Expanded, SSCI, Scopus)

51. Tongue tremor in brainstem pilocytic astrocytoma

Saka E., Ozkaynak S., Tuncer R.

JOURNAL OF CLINICAL NEUROSCIENCE , cilt.13, sa.4, ss.503-506, 2006 (SCI-Expanded, Scopus)

52. Thymus changes in anti MuSK positive and negative myasthenia gravis

SAKA TOPÇUOĞLU E., TOPÇUOĞLU M. A., AKKAYA B., GALATI A., ÖNAL m. Z., VINCENT A.

Neurology , cilt.65, ss.782-783, 2005 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 27

1. RAPAMYCIN TREATMENT ENHANCES COGNITIVE FUNCTION IN THE AAV-MEDIATED HIPPOCAMPAL ALPHA-SYNUCLEINOPATHY IN RAT

Çınar E., Yalçın Çakmaklı G., Saka Topçuoğlu E., Tel B. C., Elibol B.

14th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2019, Lisbon, Portekiz, 26 - 31 Mart 2019, (Özet Bildiri)

2. 30 yıl sonra gelişen relaps ile tanınan nmda ensefaliti olgusu

MUTLU D., TUNCER M. A., SAYGI S., ELİBOL B., SAKA TOPÇUOĞLU E.

54. ulusal nöroloji kongresi, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

3. 2000-2017 yılları arası izlenen Anti-GAD pozitif nörolojik sendrom olgularının klinik, laboratuvar ve görüntüleme özellikleri ve immün tedavi yanıtları

ERKENT İ., GÖÇMEN R., TUNCER M. A., TAN M. E., ELİBOL B., SAYGI S., et al.

54. Ulusal nöroloji kongresi, Türkiye, 30 Kasım - 06 Aralık 2018, ss.53, (Özet Bildiri)

4. A promising model for cognitive dysfunction in Parkinson’s Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

Çınar E., Yalçın Çakmaklı G., Saka Topçuoğlu E., Tel B. C., Elibol B.

22nd International Congress of Parkinson’s Disease and Movement Disorders (MDS), Victoria-City, Hong Kong, 5 - 09 Ekim 2018, (Özet Bildiri)

5. Synaptic loss predominates neuronal loss in a PD model of AAV-mediatedalpha-synuclein overexpression in hippocampus and striatum

ÇINAR E., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., ELİBOL B., TEL B. C.

18th World Congress of Basic and Clinical Pharmacology (WCP2018), 1 - 06 Temmuz 2018, (Özet Bildiri)

6. AVV-aracılı Alfa-sinüklein Aşırı İfadesine Dayalı Parkinson Hastalığı Sıçan Modelinde Motor ve Non-motor Belirtiler

ÇINAR E., YALÇIN ÇAKMAKLI G., TEL B. C., SAKA TOPÇUOĞLU E., ELİBOL B.

Ulusal Sinirbilim Kongresi, Türkiye, 20 - 23 Mayıs 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

7. AAV-aracılı Alfa-sinükleinopati Modelinde Zamana Bağlı Motor Değişiklikler

ÇINAR E., TEL B. C., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., ELİBOL B.

HÜCRE ÖLÜMÜ ARAŞTIRMA DERNEĞİULUSLARARASI KATILIMLINÖRODEJENERASYON / NÖROREJENERASYON ÇALIŞTAYI, Türkiye, 4 - 05 Mayıs 2018, (Özet Bildiri)

8. Alzheimer hastasının el yazısında harf tekrarı bulgusu. 29 Eylül-1 Ekim 2017, İstanbul.

CAVLAK M., BALSEVEN ODABAŞI A., SAKA TOPÇUOĞLU E., Genç Akpulat G. E., AKÇAN R., TÜMER A. R.

1. Ulusal Adli Belge İnceleme Kongresi, Türkiye, 29 Eylül - 01 Ekim 2017, (Özet Bildiri)

9. Adaptation of the modified mini-mental state (3MS) exam, development of a version for the undereducated, and determination of normative values in the Turkish population

CAMAN ö., KARAHAN S., BİLİR n., BARIŞKIN E., SAKA TOPÇUOĞLU E., AYHAN Y.

Alzheimer s association international conference, 2017, 16 - 20 Temmuz 2017, (Özet Bildiri)

10. DEMANS HASTALARINDA YÜZ İFADELERİNDEN DUYGU TANIMA

ÇAP D., ATKAN F., KARAHAN S., SAKA TOPÇUOĞLU E., BARIŞKIN E., AYHAN Y.

21. Klinik Eğitim Sempozyumu, Türkiye, 19 - 22 Nisan 2017, (Özet Bildiri)

11. The Maculo-Papillary Bundle and Inner Ganglion Cell Layer Are Affected More Prominently in Radiologically Isolated Syndrome

KARABUDAK R., Vural A., Acar N. P., TUNCER M. A., Sayat G., KADAYIFÇILAR S.

9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.326, (Özet Bildiri)

12. Hippocampal adeno associated viral vector mediated alpha synuclein overexpression A promising model for recapitulating cognitive involvement in Parkinson s disease

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., SAKA TOPÇUOĞLU E., Ulusoy A., TEL B. C., et al.

Society for Neuroscience, Neuroscience 2016, 12 - 16 Kasım 2016, (Özet Bildiri)

13. Hippocampal AAV mediated alpha synuclein overexpression leads to synaptic and neuronal loss with minor cognitive deficits as a Parkinson s disease model in rats

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., SAKA TOPÇUOĞLU E., Ulusoy A., TEL B. C., et al.

10th FENS Forum of Neuroscience, 2 - 06 Temmuz 2016, (Özet Bildiri)

14. Unilateral AAV mediated alpha synuclein overexpression model of Parkinson disease s to study motor and cognitive dysfunction

TEL B. C., Mutluay S. U., ÇINAR E., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., Ulusoy A., et al.

6th European Congress of Pharmacology Meeting EPHAR 2016, 26 - 30 Haziran 2016, (Özet Bildiri)

15. Unilateral AAV aracılı alfa sinüklein aşırı ifadesi ile oluşturulan PH modelinde motor ve bilişsel değişiklikler

TEL B. C., Mutluay S. U., ÇINAR E., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., Ulusoy A., et al.

14. Ulusal Sinirbilim Kongresi, Türkiye, 26 - 29 Mayıs 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Disease activity in Primary Progressive Multiple Sclerosis

Vural A., Kurne A. T., Sayat G., Derle E., KARABUDAK R.

ACTRIMS Forum, Louisiana, Amerika Birleşik Devletleri, 18 - 20 Şubat 2016, cilt.22, ss.30, (Özet Bildiri)

17. Adeno ilişkili viral vektör aracılı Parkinson hastalığı modelinde dentat girusta aşırı alfasinüklein ifadesine bağlı bilişsel fonksiyon değişikliklerinin davranışsal ve histopatolojik değerlendirilmesi

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., TELLİ G., KAZKAYASI İ., Ulusoy A., et al.

23. Ulusal Farmakoloji Kongresi, Türkiye, 7 - 09 Eylül 2015 Sürdürülebilir Kalkınma

18. Cognitive dysfunction due to over expression of alpha synuclein in hippocampus by using viral vector based approach Modeling cognitive decline in PD

TEL B. C., YALÇIN ÇAKMAKLI G., ÇINAR E., Mutluay S. U., TELLİ G., SAKA TOPÇUOĞLU E., et al.

Movement Disordes Society Meeting 2015, 14 - 18 Haziran 2015

19. Modulation of short-latency afferent inhibition (SAI) in multisystem atrophy by low frequency (1-Hz) repetitive transcranial magnetic stimulation (rTMS) of the cerebellum

Sarikaya F. G. Y., Saka E., Elibol B., Temucin C. M.

19th International Congress of Parkinson's Disease and Movement Disorders, California, Amerika Birleşik Devletleri, 14 - 18 Haziran 2015, cilt.30, (Özet Bildiri)